Bioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]

posted by qualityassurance – Jordan, 2022-08-04 15:47 (8 d 23:38 ago) – Posting: # 23202
Views: 178

Dear Ibrahim,

» Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.

I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.

Hope it may help other forum members.


Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 11 (0 registered, 11 guests [including 10 identified bots]).
Forum time: Saturday 15:25 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz